ENBREL
Pronunciation: et-a-NER-sept

What it isTNF receptor fusion protein; rheumatoid arthritis, psoriasis and ankylosing spondylitis.
Why this oneA shorter half-life than the antibody TNF blockers, so it clears faster if infection develops.
What limits itIt does NOT work in inflammatory bowel disease, unlike the antibody agents — a common misassumption. Screen for tuberculosis and hepatitis B.
Read the full label on DailyMed ↗
| FDA dosing | Population | Start | Target | Max |
|---|---|---|---|---|
| Rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis | adult | 50 mg weekly | 50 mg weekly | 50 mg weekly |
| Plaque psoriasis | adult | 50 mg twice weekly x3 months | 50 mg weekly | 50 mg twice weekly (starting) |
| Plaque psoriasis or juvenile idiopathic arthritis | pediatric | 0.8 mg/kg weekly | 0.8 mg/kg weekly | 50 mg weekly |
Renal Undefined
Hepatic Undefined
Available strengths
Pregnancy Registry data do not reliably support association with major birth defects; consider risks/benefits.
Lactation Present in low levels in human milk, minimally absorbed by breastfed infant.
| Strength | #/mo | generic $/unit | brand $/unit | CostPlus | |
|---|---|---|---|---|---|
| 50 mg/mL | inj | per unit | — | $2080.99/mL | not offered |
Generic entry2029 est. (biosimilar)
⚠ BOXED WARNINGS
Legacy pregnancy categoryC
Defining liabilitySerious infection, cytopenias, hepatic injury and malignancy risk require laboratory and clinical monitoring.
Open Etanercept in the interactive console ↗
